Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 2 Myocardial Reperfusion Injury 2 Cardiotoxicity 2 Vomiting 1 Thrombosis 1 Reperfusion Injury 1 Pain, Postoperative 1 Nausea 1 Lung Neoplasms 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Breast Neoplasms 1

Interventions

Sunitinib 5 Radiosurgery 5 Blood Specimen Collection 4 Surgical Procedures, Operative 3 fludarabine phosphate 2 Surveys and Questionnaires 2 Robotic Surgical Procedures 2 Peripheral Blood Stem Cell Transplantation 2 Methods 2 Magnetic Resonance Spectroscopy 2 Exercise 2 Cyclophosphamide 2 Cryosurgery 2 temsirolimus 1 salicylhydroxamic acid 1 perflutren 1 pazopanib 1 erythromycin propionate-N-acetylcysteinate 1 Watchful Waiting 1 Warm Ischemia 1 Varenicline 1 Urination 1 Ultrasonography, Doppler 1 Ultrasonography 1 Tyrosine Kinase Inhibitors 1 Tumor Burden 1 Traumeel S 1 Therapeutics 1 Tacrolimus 1 Surgery, Computer-Assisted 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Kidney Neoplasms × salicylhydroxamic acid × Clear all

NCT04085237 2026-06-04

ESPB

McMaster University

Phase NA Terminated

Kidney Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡